FHMLS X, L.P.
SEC CIK 1790880 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| MBX | MBX Biosciences, Inc. | 10% | 5.22M | $22.00M | — | 3 | 2024-09-16 | 2025-09-26 |
Most active insiders at MBX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | FHMLS X, L.P. | 10% | $12.00M | — |
| 2 | Azoulay Salomon | Chief Medical Off | — | $2.72M |
| 3 | Hawryluk P. Kent | Pres, CEO, Dir | $798.4K | $17.9K |
| 4 | Hoerter Steven L. | Pres, CEO, Dir | $265.0K | — |
| 5 | Bartram Richard | CFO | — | — |
| 6 | Smither John W | CFO | — | — |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-09-30 | 2025-09-26 | MBX | MBX Biosciences, Inc. | FHMLS X, L.P. | 10% | P - Purchase | $18.00 | +666.7K | 5.22M | +15% | +$12.00M |
| D | 2024-09-17 | 2024-09-16 | MBX | MBX Biosciences, Inc. | FHMLS X, L.P. | 10% | C - Cnv Deriv | — | +3.93M | 3.93M | New | — |
| D | 2024-09-17 | 2024-09-16 | MBX | MBX Biosciences, Inc. | FHMLS X, L.P. | 10% | P - Purchase | $16.00 | +625.0K | 4.55M | +16% | +$10.00M |
Purchase Sale Sale after option exercise All abbreviations